Prospective evaluation of insulin resistance among endometrial cancer patients
- PMID: 21324431
- PMCID: PMC4286377
- DOI: 10.1016/j.ajog.2010.11.033
Prospective evaluation of insulin resistance among endometrial cancer patients
Abstract
Objective: Obesity and estrogen are strong risk factors for endometrial cancer (EC). Whereas diabetes also increases the risk, little is known about related insulin resistance (IR). The purpose of this study was to determine the prevalence of IR in newly diagnosed EC patients.
Study design: EC patients from a large, metropolitan county were prospectively enrolled from 2005 to 2008. Fasting serum was analyzed for glucose and insulin. IR was defined as a history of diabetes or a quantitative insulin sensitivity check index (QUICKI) (1/[log fasting insulin + log fasting glucose]) value of less than 0.357.
Results: Among 99 patients, diabetes was present in 30, and an abnormal QUICKI was found in 36 additional patients. Increased risk of IR was significantly associated with higher body mass index (P < .001), lower socioeconomic status (P = .007), and nulliparity (P = .029).
Conclusion: IR was highly prevalent in endometrial cancer patients, including nonobese women. Better characterization of metabolic risks in addition to obesity may provide avenues for targeted cancer prevention in the future.
Copyright © 2011 Mosby, Inc. All rights reserved.
Figures
Similar articles
-
Prospective evaluation of abnormal glucose metabolism and insulin resistance in patients with atypical endometrial hyperplasia and endometrial cancer.Support Care Cancer. 2017 May;25(5):1495-1501. doi: 10.1007/s00520-016-3554-y. Epub 2016 Dec 27. Support Care Cancer. 2017. PMID: 28028620
-
Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings.PLoS One. 2021 Mar 31;16(3):e0248469. doi: 10.1371/journal.pone.0248469. eCollection 2021. PLoS One. 2021. PMID: 33788827 Free PMC article.
-
Comparison of insulin resistance and serum high-sensitivity C-reactive protein levels according to the fasting blood glucose subgroups divided by the newly recommended criteria for fasting hyperglycemia in 10059 healthy Koreans.Metabolism. 2006 Feb;55(2):183-7. doi: 10.1016/j.metabol.2005.08.010. Metabolism. 2006. PMID: 16423624
-
Insulin resistance and endometrial cancer risk: A systematic review and meta-analysis.Eur J Cancer. 2015 Dec;51(18):2747-58. doi: 10.1016/j.ejca.2015.08.031. Epub 2015 Nov 18. Eur J Cancer. 2015. PMID: 26597445 Review.
-
[Molecular action of insulin-sensitizing agents].Endokrynol Pol. 2005 May-Jun;56(3):308-13. Endokrynol Pol. 2005. PMID: 16350724 Review. Polish.
Cited by
-
Personalized therapy in endometrial cancer: challenges and opportunities.Cancer Biol Ther. 2012 Jan 1;13(1):1-13. doi: 10.4161/cbt.13.1.18438. Epub 2012 Jan 1. Cancer Biol Ther. 2012. PMID: 22198566 Free PMC article. Review.
-
The Effect of Metformin on Expression of Long Non-coding RNA H19 in Endometrial Cancer.Med J Islam Repub Iran. 2021 Nov 22;35:155. doi: 10.47176/mjiri.35.155. eCollection 2021. Med J Islam Repub Iran. 2021. PMID: 35341081 Free PMC article.
-
The insulin sensitivity Mcauley index (MCAi) is associated with 40-year cancer mortality in a cohort of men and women free of diabetes at baseline.PLoS One. 2022 Aug 3;17(8):e0272437. doi: 10.1371/journal.pone.0272437. eCollection 2022. PLoS One. 2022. PMID: 35921366 Free PMC article.
-
Measuring the biological effect of presurgical metformin treatment in endometrial cancer.Br J Cancer. 2016 Feb 2;114(3):281-9. doi: 10.1038/bjc.2015.453. Epub 2016 Jan 21. Br J Cancer. 2016. PMID: 26794276 Free PMC article. Clinical Trial.
-
YAP/TAZ regulates the insulin signaling via IRS1/2 in endometrial cancer.Am J Cancer Res. 2016 May 1;6(5):996-1010. eCollection 2016. Am J Cancer Res. 2016. PMID: 27293994 Free PMC article.
References
-
- Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010 Epub. - PubMed
-
- Brinton LA, Berman ML, Mortel R, et al. Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol. 1992;167:1317–1325. - PubMed
-
- Elwood JM, Cole P, Rothman KJ, Kaplan SD. Epidemiology of endometrial cancer. J Natl Cancer Inst. 1977;59:1055–1060. - PubMed
-
- Goodman MT, Hankin JH, Wilkens LR, et al. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res. 1997;57:5077–5085. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources